Pfizer (PFE) Receives EC Approval for Expanded Prevenar 13 Indication for Pneumonia Prevention
Tweet Send to a Friend
Pfizer (NYSE: PFE) announced that the European Commission approved an expanded indication for the use of Prevenar 13* (pneumococcal polysaccharide ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
